94MO Quality of life (QoL) with fulvestrant (FUL)/palbociclib (PAL) versus FUL/placebo (PBO) in postmenopausal women with hormone receptor (HR)+/HER2- endocrine sensitive advanced breast cancer (ABC): Results from GEICAM/2014-12 (FLIPPER) study
Titel:
94MO Quality of life (QoL) with fulvestrant (FUL)/palbociclib (PAL) versus FUL/placebo (PBO) in postmenopausal women with hormone receptor (HR)+/HER2- endocrine sensitive advanced breast cancer (ABC): Results from GEICAM/2014-12 (FLIPPER) study
Auteur:
Tibau, A. Martinez, M.T. Ramos, M. De la Cruz-Merino, L. Santaballa, A. Connor, M. O' Martinez-Jañez, N. Moreno, F. Fernandez-Perez, I. Virizuela, J.A. Alarcón, J. de la Haba-Rodríguez, J. Sánchez-Rovira, P. Albacar, C.R. Bueno, C. Kelly, C. Casas, M. Bezares, S. Rosell, L. Albanell, J.